Panelists discuss how transplant eligibility should be viewed as a continuum based on frailty rather than a binary decision, with most patients collecting stem cells but only about 20% receiving delayed transplants.
Sagar Lonial, MD, FACP, FASCO
Advertisement
Articles by Sagar Lonial, MD, FACP, FASCO
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Tucatinib Plus Trastuzumab/Pertuzumab as First-Line Maintenance in Advanced HER2+ Breast Cancer
2
FDA Approves Atezolizumab Plus Chemo for Stage III dMMR Colon Cancer
3
VIR-5500 Receives FDA Fast Track Designation in mCRPC
4
The OncFive: Top Oncology Articles for the Week of 10/4/2026
5